Basit öğe kaydını göster

dc.contributor.authorKurul, S
dc.contributor.authorAydin, T
dc.contributor.authorSaip, P
dc.date.accessioned2021-03-03T12:55:25Z
dc.date.available2021-03-03T12:55:25Z
dc.date.issued2002
dc.identifier.citationKurul S., Saip P., Aydin T., "Totally implantable venous-access ports: local problems and extravasation injury", LANCET ONCOLOGY, cilt.3, sa.11, ss.684-692, 2002
dc.identifier.issn1470-2045
dc.identifier.otherav_30e22de3-170b-4a86-9f01-6e6ec8f27750
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/37312
dc.identifier.urihttps://doi.org/10.1016/s1470-2045(02)00905-1
dc.description.abstractTotally implantable venous-access ports (TIVAPs) are valuable instruments for long-term intravenous treatment of patients with cancer, but implantation and use of these devices are each associated with complications. In addition to the perioperative problems, long-term complications can arise; these can be classified in five categories -catheter malfunction, catheter-related venous thrombosis, catheter-related infection, port-related complications, and extravasation injury. Such complications reduce the benefits of reliable access to the venous system in patients with malignant tumours. The vast majority of such disadvantages are attributable to inexpert handling of ports and, therefore, should be avoidable. TIVAP placement procedures and TIVAP complications are discussed in this review, with special emphasis on local problems and extravasation injuries. To obtain maximum benefit from TIVAPs, all health-care personnel must be familiar with the use and routine maintenance procedures of the devices and treatment options for catheter-related complications.
dc.language.isoeng
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleTotally implantable venous-access ports: local problems and extravasation injury
dc.typeMakale
dc.relation.journalLANCET ONCOLOGY
dc.contributor.department, ,
dc.identifier.volume3
dc.identifier.issue11
dc.identifier.startpage684
dc.identifier.endpage692
dc.contributor.firstauthorID166286


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster